-
1
-
-
0024602758
-
Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells
-
Capranico G, De Isabella P, Penco S, Tinelli S and Zunino F. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells. Cancer Res. 1989; 49(8):2022-2027.
-
(1989)
Cancer Res.
, vol.49
, Issue.8
, pp. 2022-2027
-
-
Capranico, G.1
De Isabella, P.2
Penco, S.3
Tinelli, S.4
Zunino, F.5
-
2
-
-
0032508504
-
Enhanced phosphorylation of p53 by ATM in response to DNA damage
-
Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 1998; 281(5383):1674-1677.
-
(1998)
Science.
, vol.281
, Issue.5383
, pp. 1674-1677
-
-
Banin, S.1
Moyal, L.2
Shieh, S.3
Taya, Y.4
Anderson, C.W.5
Chessa, L.6
Smorodinsky, N.I.7
Prives, C.8
Reiss, Y.9
Shiloh, Y.10
Ziv, Y.11
-
3
-
-
33644538632
-
Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli
-
Wu ZH, Shi Y, Tibbetts RS and Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science. 2006; 311(5764):1141-1146.
-
(2006)
Science.
, vol.311
, Issue.5764
, pp. 1141-1146
-
-
Wu, Z.H.1
Shi, Y.2
Tibbetts, R.S.3
Miyamoto, S.4
-
4
-
-
0038771214
-
Modulation of NF-kappaB activity by exchange of dimers
-
Saccani S, Pantano S and Natoli G. Modulation of NF-kappaB activity by exchange of dimers. Mol Cell. 2003; 11(6):1563-1574.
-
(2003)
Mol Cell.
, vol.11
, Issue.6
, pp. 1563-1574
-
-
Saccani, S.1
Pantano, S.2
Natoli, G.3
-
5
-
-
84858734708
-
NF-kappaB and chromatin: ten years on the path from basic mechanisms to candidate drugs
-
Natoli G. NF-kappaB and chromatin: ten years on the path from basic mechanisms to candidate drugs. Immunol Rev. 2012; 246(1):183-192.
-
(2012)
Immunol Rev.
, vol.246
, Issue.1
, pp. 183-192
-
-
Natoli, G.1
-
6
-
-
84858720357
-
Celebrating 25 years of NF-kappaB research
-
Ghosh S and Hayden MS. Celebrating 25 years of NF-kappaB research. Immunol Rev. 2012; 246(1):5-13.
-
(2012)
Immunol Rev.
, vol.246
, Issue.1
, pp. 5-13
-
-
Ghosh, S.1
Hayden, M.S.2
-
7
-
-
33750283069
-
MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo
-
Hideshima T, Neri P, Tassone P, Yasui H, Ishitsuka K, Raje N, Chauhan D, Podar K, Mitsiades C, Dang L, Munshi N, Richardson P, Schenkein D and Anderson KC. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo. Clin Cancer Res. 2006; 12(19):5887-5894.
-
(2006)
Clin Cancer Res.
, vol.12
, Issue.19
, pp. 5887-5894
-
-
Hideshima, T.1
Neri, P.2
Tassone, P.3
Yasui, H.4
Ishitsuka, K.5
Raje, N.6
Chauhan, D.7
Podar, K.8
Mitsiades, C.9
Dang, L.10
Munshi, N.11
Richardson, P.12
Schenkein, D.13
Anderson, K.C.14
-
8
-
-
35148880568
-
Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin
-
Tapia MA, Gonzalez-Navarrete I, Dalmases A, Bosch M, Rodriguez-Fanjul V, Rolfe M, Ross JS, Mezquita J, Mezquita C, Bachs O, Gascon P, Rojo F, Perona R, Rovira A and Albanell J. Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin. Cell Cycle. 2007; 6(18):2284-2292.
-
(2007)
Cell Cycle.
, vol.6
, Issue.18
, pp. 2284-2292
-
-
Tapia, M.A.1
Gonzalez-Navarrete, I.2
Dalmases, A.3
Bosch, M.4
Rodriguez-Fanjul, V.5
Rolfe, M.6
Ross, J.S.7
Mezquita, J.8
Mezquita, C.9
Bachs, O.10
Gascon, P.11
Rojo, F.12
Perona, R.13
Rovira, A.14
Albanell, J.15
-
9
-
-
23044498269
-
Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells
-
Li Y, Ahmed F, Ali S, Philip PA, Kucuk O and Sarkar FH. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res. 2005; 65(15):6934-6942.
-
(2005)
Cancer Res.
, vol.65
, Issue.15
, pp. 6934-6942
-
-
Li, Y.1
Ahmed, F.2
Ali, S.3
Philip, P.A.4
Kucuk, O.5
Sarkar, F.H.6
-
10
-
-
0038682199
-
Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
-
Yeh PY, Chuang SE, Yeh KH, Song YC and Cheng AL. Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells. Biochem Pharmacol. 2003; 66(1):25-33.
-
(2003)
Biochem Pharmacol.
, vol.66
, Issue.1
, pp. 25-33
-
-
Yeh, P.Y.1
Chuang, S.E.2
Yeh, K.H.3
Song, Y.C.4
Cheng, A.L.5
-
11
-
-
84872758096
-
Inhibition of specific NF-kappaB activity contributes to the tumor suppressor function of 14-3-3sigma in breast cancer
-
Ingles-Esteve J, Morales M, Dalmases A, Garcia-Carbonell R, Jene-Sanz A, Lopez-Bigas N, Iglesias M, Ruiz-Herguido C, Rovira A, Rojo F, Albanell J, Gomis RR, Bigas A and Espinosa L. Inhibition of specific NF-kappaB activity contributes to the tumor suppressor function of 14-3-3sigma in breast cancer. PLoS One. 2012; 7(5):e38347.
-
(2012)
PLoS One.
, vol.7
, Issue.5
-
-
Ingles-Esteve, J.1
Morales, M.2
Dalmases, A.3
Garcia-Carbonell, R.4
Jene-Sanz, A.5
Lopez-Bigas, N.6
Iglesias, M.7
Ruiz-Herguido, C.8
Rovira, A.9
Rojo, F.10
Albanell, J.11
Gomis, R.R.12
Bigas, A.13
Espinosa, L.14
-
12
-
-
33745094348
-
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients
-
Montagut C, Tusquets I, Ferrer B, Corominas JM, Bellosillo B, Campas C, Suarez M, Fabregat X, Campo E, Gascon P, Serrano S, Fernandez PL, Rovira A and Albanell J. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer. 2006; 13(2):607-616.
-
(2006)
Endocr Relat Cancer.
, vol.13
, Issue.2
, pp. 607-616
-
-
Montagut, C.1
Tusquets, I.2
Ferrer, B.3
Corominas, J.M.4
Bellosillo, B.5
Campas, C.6
Suarez, M.7
Fabregat, X.8
Campo, E.9
Gascon, P.10
Serrano, S.11
Fernandez, P.L.12
Rovira, A.13
Albanell, J.14
-
13
-
-
28544448482
-
The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer
-
Buchholz TA, Garg AK, Chakravarti N, Aggarwal BB, Esteva FJ, Kuerer HM, Singletary SE, Hortobagyi GN, Pusztai L, Cristofanilli M and Sahin AA. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. Clin Cancer Res. 2005; 11(23):8398-8402.
-
(2005)
Clin Cancer Res.
, vol.11
, Issue.23
, pp. 8398-8402
-
-
Buchholz, T.A.1
Garg, A.K.2
Chakravarti, N.3
Aggarwal, B.B.4
Esteva, F.J.5
Kuerer, H.M.6
Singletary, S.E.7
Hortobagyi, G.N.8
Pusztai, L.9
Cristofanilli, M.10
Sahin, A.A.11
-
14
-
-
27944434722
-
Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse
-
Domingo-Domenech J, Mellado B, Ferrer B, Truan D, Codony-Servat J, Sauleda S, Alcover J, Campo E, Gascon P, Rovira A, Ross JS, Fernandez PL and Albanell J. Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer. 2005; 93(11):1285-1294.
-
(2005)
Br J Cancer.
, vol.93
, Issue.11
, pp. 1285-1294
-
-
Domingo-Domenech, J.1
Mellado, B.2
Ferrer, B.3
Truan, D.4
Codony-Servat, J.5
Sauleda, S.6
Alcover, J.7
Campo, E.8
Gascon, P.9
Rovira, A.10
Ross, J.S.11
Fernandez, P.L.12
Albanell, J.13
-
15
-
-
77649341172
-
Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy
-
Li F and Sethi G. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta. 2010; 1805(2):167-180.
-
(2010)
Biochim Biophys Acta.
, vol.1805
, Issue.2
, pp. 167-180
-
-
Li, F.1
Sethi, G.2
-
16
-
-
20144365514
-
Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells
-
Ho WC, Dickson KM and Barker PA. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. Cancer Res. 2005; 65(10):4273-4281.
-
(2005)
Cancer Res.
, vol.65
, Issue.10
, pp. 4273-4281
-
-
Ho, W.C.1
Dickson, K.M.2
Barker, P.A.3
-
17
-
-
80054761315
-
Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor
-
Murphy SH, Suzuki K, Downes M, Welch GL, De Jesus P, Miraglia LJ, Orth AP, Chanda SK, Evans RM and Verma IM. Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor. Proc Natl Acad Sci U S A. 2011; 108(41):17117-17122.
-
(2011)
Proc Natl Acad Sci U S A.
, vol.108
, Issue.41
, pp. 17117-17122
-
-
Murphy, S.H.1
Suzuki, K.2
Downes, M.3
Welch, G.L.4
De Jesus, P.5
Miraglia, L.J.6
Orth, A.P.7
Chanda, S.K.8
Evans, R.M.9
Verma, I.M.10
-
18
-
-
84877028141
-
Comprehensive molecular portraits of human breast tumours
-
Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70.
-
(2012)
Nature
, vol.490
, Issue.7418
, pp. 61-70
-
-
-
19
-
-
84877823153
-
Mutant p53 prolongs NF-kappaB activation and promotes chronic inflammation and inflammation-associated colorectal cancer
-
Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, Harpaz N, Itzkowitz S, Harris CC, Rotter V, Gorgoulis VG and Oren M. Mutant p53 prolongs NF-kappaB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell. 2013; 23(5):634-646.
-
(2013)
Cancer Cell.
, vol.23
, Issue.5
, pp. 634-646
-
-
Cooks, T.1
Pateras, I.S.2
Tarcic, O.3
Solomon, H.4
Schetter, A.J.5
Wilder, S.6
Lozano, G.7
Pikarsky, E.8
Forshew, T.9
Rosenfeld, N.10
Harpaz, N.11
Itzkowitz, S.12
Harris, C.C.13
Rotter, V.14
Gorgoulis, V.G.15
Oren, M.16
-
20
-
-
45149089389
-
A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients
-
Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Borresen-Dale AL and Overgaard J. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients. Acta Oncol. 2008; 47(4):600-607.
-
(2008)
Acta Oncol.
, vol.47
, Issue.4
, pp. 600-607
-
-
Alsner, J.1
Jensen, V.2
Kyndi, M.3
Offersen, B.V.4
Vu, P.5
Borresen-Dale, A.L.6
Overgaard, J.7
-
21
-
-
70349173433
-
Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin
-
Bednarski BK, Baldwin AS, Jr. and Kim HJ. Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin. PLoS One. 2009; 4(9):e6992.
-
(2009)
PLoS One.
, vol.4
, Issue.9
-
-
Bednarski, B.K.1
Baldwin, A.S.2
Kim, H.J.3
-
22
-
-
79960419007
-
NF-kappaB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-kappaB activation
-
Hadian K, Griesbach RA, Dornauer S, Wanger TM, Nagel D, Metlitzky M, Beisker W, Schmidt-Supprian M and Krappmann D. NF-kappaB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-kappaB activation. J Biol Chem. 2011; 286(29):26107-26117.
-
(2011)
J Biol Chem.
, vol.286
, Issue.29
, pp. 26107-26117
-
-
Hadian, K.1
Griesbach, R.A.2
Dornauer, S.3
Wanger, T.M.4
Nagel, D.5
Metlitzky, M.6
Beisker, W.7
Schmidt-Supprian, M.8
Krappmann, D.9
-
23
-
-
0035966071
-
NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells
-
Bian X, McAllister-Lucas LM, Shao F, Schumacher KR, Feng Z, Porter AG, Castle VP and Opipari AW, Jr. NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem. 2001; 276(52):48921-48929.
-
(2001)
J Biol Chem.
, vol.276
, Issue.52
, pp. 48921-48929
-
-
Bian, X.1
McAllister-Lucas, L.M.2
Shao, F.3
Schumacher, K.R.4
Feng, Z.5
Porter, A.G.6
Castle, V.P.7
Opipari, A.W.8
-
24
-
-
54849417187
-
Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells
-
Chen W, Wang X, Bai L, Liang X, Zhuang J and Lin Y. Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells. J Cell Biochem. 2008; 105(2):554-561.
-
(2008)
J Cell Biochem.
, vol.105
, Issue.2
, pp. 554-561
-
-
Chen, W.1
Wang, X.2
Bai, L.3
Liang, X.4
Zhuang, J.5
Lin, Y.6
-
25
-
-
1842526076
-
Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B
-
Campbell KJ, Rocha S and Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell. 2004; 13(6):853-865.
-
(2004)
Mol Cell.
, vol.13
, Issue.6
, pp. 853-865
-
-
Campbell, K.J.1
Rocha, S.2
Perkins, N.D.3
-
26
-
-
33646555078
-
Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors
-
Campbell KJ, O'Shea JM and Perkins ND. Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors. BMC Cancer. 2006; 6:101.
-
(2006)
BMC Cancer.
, vol.6
, pp. 101
-
-
Campbell, K.J.1
O'Shea, J.M.2
Perkins, N.D.3
-
27
-
-
3943054838
-
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling
-
Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV and Dixit VM. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004; 430(7000):694-699.
-
(2004)
Nature.
, vol.430
, Issue.7000
, pp. 694-699
-
-
Wertz, I.E.1
O'Rourke, K.M.2
Zhou, H.3
Eby, M.4
Aravind, L.5
Seshagiri, S.6
Wu, P.7
Wiesmann, C.8
Baker, R.9
Boone, D.L.10
Ma, A.11
Koonin, E.V.12
Dixit, V.M.13
-
28
-
-
0033054012
-
A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma
-
Codd JD, Salisbury JR, Packham G and Nicholson LJ. A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J Pathol. 1999; 187(5):549-555.
-
(1999)
J Pathol.
, vol.187
, Issue.5
, pp. 549-555
-
-
Codd, J.D.1
Salisbury, J.R.2
Packham, G.3
Nicholson, L.J.4
-
29
-
-
34447507710
-
A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells
-
Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N and Cohen PA. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene. 2007; 26(32):4656-4667.
-
(2007)
Oncogene.
, vol.26
, Issue.32
, pp. 4656-4667
-
-
Vendrell, J.A.1
Ghayad, S.2
Ben-Larbi, S.3
Dumontet, C.4
Mechti, N.5
Cohen, P.A.6
-
30
-
-
33644822862
-
Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas
-
Bredel M, Bredel C, Juric D, Duran GE, Yu RX, Harsh GR, Vogel H, Recht LD, Scheck AC and Sikic BI. Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006; 24(2):274-287.
-
(2006)
J Clin Oncol.
, vol.24
, Issue.2
, pp. 274-287
-
-
Bredel, M.1
Bredel, C.2
Juric, D.3
Duran, G.E.4
Yu, R.X.5
Harsh, G.R.6
Vogel, H.7
Recht, L.D.8
Scheck, A.C.9
Sikic, B.I.10
-
31
-
-
53449093919
-
The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines
-
Brooks KJ, Coleman EJ and Vitetta ES. The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines. Int J Cancer. 2008; 123(10):2438-2445.
-
(2008)
Int J Cancer.
, vol.123
, Issue.10
, pp. 2438-2445
-
-
Brooks, K.J.1
Coleman, E.J.2
Vitetta, E.S.3
-
32
-
-
40949111793
-
Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study
-
Dowlati A, Gray R, Sandler AB, Schiller JH and Johnson DH. Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study. Clin Cancer Res. 2008; 14(5):1407-1412.
-
(2008)
Clin Cancer Res.
, vol.14
, Issue.5
, pp. 1407-1412
-
-
Dowlati, A.1
Gray, R.2
Sandler, A.B.3
Schiller, J.H.4
Johnson, D.H.5
-
33
-
-
79961173514
-
Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer
-
Schroder C, Witzel I, Muller V, Krenkel S, Wirtz RM, Janicke F, Schumacher U and Milde-Langosch K. Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer. J Cancer Res Clin Oncol. 2011; 137(8):1193-1201.
-
(2011)
J Cancer Res Clin Oncol.
, vol.137
, Issue.8
, pp. 1193-1201
-
-
Schroder, C.1
Witzel, I.2
Muller, V.3
Krenkel, S.4
Wirtz, R.M.5
Janicke, F.6
Schumacher, U.7
Milde-Langosch, K.8
-
34
-
-
79961175789
-
Influence of a dose-dense adjuvant chemotherapy on sVCAM-1/sICAM-1 serum levels in breast cancer patients with 1-3 positive lymph nodes
-
Eggeman H, Stoblen F, Thill M, Korlach S, Schmid P, Luftner D, Elling D, Taran FA, Kummel S and Landt S. Influence of a dose-dense adjuvant chemotherapy on sVCAM-1/sICAM-1 serum levels in breast cancer patients with 1-3 positive lymph nodes. Anticancer Res. 2011; 31(8):2617-2622.
-
(2011)
Anticancer Res.
, vol.31
, Issue.8
, pp. 2617-2622
-
-
Eggeman, H.1
Stoblen, F.2
Thill, M.3
Korlach, S.4
Schmid, P.5
Luftner, D.6
Elling, D.7
Taran, F.A.8
Kummel, S.9
Landt, S.10
-
35
-
-
67651005826
-
Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer
-
Bierie B, Chung CH, Parker JS, Stover DG, Cheng N, Chytil A, Aakre M, Shyr Y and Moses HL. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. J Clin Invest. 2009; 119(6):1571-1582.
-
(2009)
J Clin Invest.
, vol.119
, Issue.6
, pp. 1571-1582
-
-
Bierie, B.1
Chung, C.H.2
Parker, J.S.3
Stover, D.G.4
Cheng, N.5
Chytil, A.6
Aakre, M.7
Shyr, Y.8
Moses, H.L.9
-
36
-
-
84863625224
-
A CXCL1 paracrine network links cancer chemoresistance and metastasis
-
Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, Norton L, Brogi E and Massague J. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012; 150(1):165-178.
-
(2012)
Cell.
, vol.150
, Issue.1
, pp. 165-178
-
-
Acharyya, S.1
Oskarsson, T.2
Vanharanta, S.3
Malladi, S.4
Kim, J.5
Morris, P.G.6
Manova-Todorova, K.7
Leversha, M.8
Hogg, N.9
Seshan, V.E.10
Norton, L.11
Brogi, E.12
Massague, J.13
-
38
-
-
0032954928
-
Transcriptional cross talk between NF-kappaB and p53
-
Webster GA and Perkins ND. Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol. 1999; 19(5):3485-3495.
-
(1999)
Mol Cell Biol.
, vol.19
, Issue.5
, pp. 3485-3495
-
-
Webster, G.A.1
Perkins, N.D.2
-
39
-
-
82755176687
-
Curcumin enhances the efficacy of chemotherapy by tailoring p65NFkappaB-p300 cross-talk in favor of p53-p300 in breast cancer
-
Sen GS, Mohanty S, Hossain DM, Bhattacharyya S, Banerjee S, Chakraborty J, Saha S, Ray P, Bhattacharjee P, Mandal D, Bhattacharya A, Chattopadhyay S, Das T and Sa G. Curcumin enhances the efficacy of chemotherapy by tailoring p65NFkappaB-p300 cross-talk in favor of p53-p300 in breast cancer. J Biol Chem. 2011; 286(49):42232-42247.
-
(2011)
J Biol Chem.
, vol.286
, Issue.49
, pp. 42232-42247
-
-
Sen, G.S.1
Mohanty, S.2
Hossain, D.M.3
Bhattacharyya, S.4
Banerjee, S.5
Chakraborty, J.6
Saha, S.7
Ray, P.8
Bhattacharjee, P.9
Mandal, D.10
Bhattacharya, A.11
Chattopadhyay, S.12
Das, T.13
Sa, G.14
-
40
-
-
12144272815
-
Estrogen and progesterone receptor isoforms: clinical significance in breast cancer
-
Fuqua SA and Cui Y. Estrogen and progesterone receptor isoforms: clinical significance in breast cancer. Breast Cancer Res Treat. 2004; 87 Suppl 1:S3-10.
-
(2004)
Breast Cancer Res Treat
, vol.87
, Issue.SUPPL. 1
-
-
Fuqua, S.A.1
Cui, Y.2
-
41
-
-
23244447215
-
Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation
-
Liu H, Liu K and Bodenner DL. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation. Cytokine. 2005; 31(4):251-257.
-
(2005)
Cytokine.
, vol.31
, Issue.4
, pp. 251-257
-
-
Liu, H.1
Liu, K.2
Bodenner, D.L.3
-
42
-
-
66749103282
-
NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells
-
Gionet N, Jansson D, Mader S and Pratt MA. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells. J Cell Biochem. 2009; 107(3):448-459.
-
(2009)
J Cell Biochem.
, vol.107
, Issue.3
, pp. 448-459
-
-
Gionet, N.1
Jansson, D.2
Mader, S.3
Pratt, M.A.4
-
43
-
-
84872370561
-
Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors
-
Schwitalla S, Ziegler PK, Horst D, Becker V, Kerle I, Begus-Nahrmann Y, Lechel A, Rudolph KL, Langer R, Slotta-Huspenina J, Bader FG, Prazeres da Costa O, Neurath MF, Meining A, Kirchner T and Greten FR. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell. 2013; 23(1):93-106.
-
(2013)
Cancer Cell.
, vol.23
, Issue.1
, pp. 93-106
-
-
Schwitalla, S.1
Ziegler, P.K.2
Horst, D.3
Becker, V.4
Kerle, I.5
Begus-Nahrmann, Y.6
Lechel, A.7
Rudolph, K.L.8
Langer, R.9
Slotta-Huspenina, J.10
Bader, F.G.11
Prazeres da Costa, O.12
Neurath, M.F.13
Meining, A.14
Kirchner, T.15
Greten, F.R.16
-
44
-
-
35348918435
-
A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status
-
Lee TL, Yang XP, Yan B, Friedman J, Duggal P, Bagain L, Dong G, Yeh NT, Wang J, Zhou J, Elkahloun A, Van Waes C and Chen Z. A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status. Clin Cancer Res. 2007; 13(19):5680-5691.
-
(2007)
Clin Cancer Res.
, vol.13
, Issue.19
, pp. 5680-5691
-
-
Lee, T.L.1
Yang, X.P.2
Yan, B.3
Friedman, J.4
Duggal, P.5
Bagain, L.6
Dong, G.7
Yeh, N.T.8
Wang, J.9
Zhou, J.10
Elkahloun, A.11
Van Waes, C.12
Chen, Z.13
-
45
-
-
0031034469
-
Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins
-
Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R and Lacal JC. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 1997; 11(4):463-475.
-
(1997)
Genes Dev.
, vol.11
, Issue.4
, pp. 463-475
-
-
Perona, R.1
Montaner, S.2
Saniger, L.3
Sanchez-Perez, I.4
Bravo, R.5
Lacal, J.C.6
-
46
-
-
66149167313
-
Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin
-
Rojo F, Gonzalez-Navarrete I, Bragado R, Dalmases A, Menendez S, Cortes-Sempere M, Suarez C, Oliva C, Servitja S, Rodriguez-Fanjul V, Sanchez-Perez I, Campas C, Corominas JM, Tusquets I, Bellosillo B, Serrano S, et al. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin. Clin Cancer Res. 2009; 15(10):3530-3539.
-
(2009)
Clin Cancer Res.
, vol.15
, Issue.10
, pp. 3530-3539
-
-
Rojo, F.1
Gonzalez-Navarrete, I.2
Bragado, R.3
Dalmases, A.4
Menendez, S.5
Cortes-Sempere, M.6
Suarez, C.7
Oliva, C.8
Servitja, S.9
Rodriguez-Fanjul, V.10
Sanchez-Perez, I.11
Campas, C.12
Corominas, J.M.13
Tusquets, I.14
Bellosillo, B.15
Serrano, S.16
-
47
-
-
0026072872
-
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up
-
Elston CW and Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19(5):403-410.
-
(1991)
Histopathology.
, vol.19
, Issue.5
, pp. 403-410
-
-
Elston, C.W.1
Ellis, I.O.2
-
48
-
-
77954526150
-
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
-
Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010; 28(16):2784-2795.
-
(2010)
J Clin Oncol.
, vol.28
, Issue.16
, pp. 2784-2795
-
-
Hammond, M.E.1
Hayes, D.F.2
Dowsett, M.3
Allred, D.C.4
Hagerty, K.L.5
Badve, S.6
Fitzgibbons, P.L.7
Francis, G.8
Goldstein, N.S.9
Hayes, M.10
Hicks, D.G.11
Lester, S.12
Love, R.13
Mangu, P.B.14
McShane, L.15
Miller, K.16
-
49
-
-
33847147313
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
-
Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007; 25(1):118-145.
-
(2007)
J Clin Oncol.
, vol.25
, Issue.1
, pp. 118-145
-
-
Wolff, A.C.1
Hammond, M.E.2
Schwartz, J.N.3
Hagerty, K.L.4
Allred, D.C.5
Cote, R.J.6
Dowsett, M.7
Fitzgibbons, P.L.8
Hanna, W.M.9
Langer, A.10
McShane, L.M.11
Paik, S.12
Pegram, M.D.13
Perez, E.A.14
Press, M.F.15
Rhodes, A.16
-
50
-
-
27244443082
-
Proliferation marker Ki-67 in early breast cancer
-
Urruticoechea A, Smith IE and Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005; 23(28):7212-7220.
-
(2005)
J Clin Oncol.
, vol.23
, Issue.28
, pp. 7212-7220
-
-
Urruticoechea, A.1
Smith, I.E.2
Dowsett, M.3
-
51
-
-
33644830699
-
Reporting recommendations for tumor marker prognostic studies
-
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M and Clark GM. Reporting recommendations for tumor marker prognostic studies. J Clin Oncol. 2005; 23(36):9067-9072.
-
(2005)
J Clin Oncol.
, vol.23
, Issue.36
, pp. 9067-9072
-
-
McShane, L.M.1
Altman, D.G.2
Sauerbrei, W.3
Taube, S.E.4
Gion, M.5
Clark, G.M.6
|